-
1Academic Journal
-
2Academic Journal
المؤلفون: Toungoussova, O. S., Mariandyshev, A., Bjune, G., Sandven, P., Caugant, D. A.
المصدر: Clinical Infectious Diseases ; volume 37, issue 5, page 665-672 ; ISSN 1058-4838 1537-6591
-
3
المؤلفون: Migliori, G. B., Lange, C., Centis, R., Sotgiu, G., Mutterlein, R., Hoffmann, H., Kliiman, K., De Iaco, G., Lauria, F. N., Richardson, M. D., Spanevello, A., Cirillo, D. M., Ortmann, J., Kirsten, D., Ruesch Gerdes, S., Piana, F., Gori, A., Codecasa, L. R., Ferrarese, M., Toungoussova, O. S., Ferrara, Giovanni, Matteelli, A., De Lorenzo, S., Troupioti, P., Besozzi, G., Fattorini, L., Iona, E., Gualano, A., De Mori, P., Bevilacqua, N., Girardi, E., Danilovits, M., Hollo, V., Mariandyshev, A.
المصدر: European Respiratory Journal. 31:1155-1159
مصطلحات موضوعية: Estonia, Pulmonary and Respiratory Medicine, Drug, medicine.medical_specialty, Tuberculosis, Settore MED/17 - Malattie Infettive, Capreomycin, FLUOROQUINOLONES, Extensively Drug-Resistant Tuberculosis, media_common.quotation_subject, Drug Resistance, Antitubercular Agents, Drug resistance, Injections, Russia, Mycobacterium tuberculosis, Multidrug-resistant tuberculosis, Drug Resistance, Multiple, Bacterial, Germany, Internal medicine, tuberculosis MYCOBACTERIUM-TUBERCULOSIS, Humans, Medicine, Registries, Treatment Failure, XDR-TB, media_common, biology, business.industry, Bacterial, Extensively drug-resistant tuberculosis, Odds ratio, biology.organism_classification, medicine.disease, Survival Analysis, Injectable second-line drugs, Injections, Intravenous, Italy, Surgery, Multiple drug resistance, drug resistance, extensively drug-resistant tuberculosis, injectable second-line drugs, multidrug-resistant tuberculosis, tuberculosis MYCOBACTERIUM-TUBERCULOSIS, XDR-TB, FLUOROQUINOLONES, Intravenous, business, Multiple, medicine.drug
-
4Academic Journal
المؤلفون: Migliori G. B., Besozzi G., Girardi E., Kliiman K., Lange C., Toungoussova O. S., Ferrara G., Cirillo D. M., Gori A., Matteelli A., Spanevello A., Codecasa L. R., Raviglione M. C., Ortmann J., Kirsten D., Ruesch-Gerdes S., Piana F., Ferrarese M., De Iaco G., De Lorenzo S., Troupioti P., Fattorini L., Iona E., Gualano A., De Mori P., Centis R., Danilovits M., Hollo V., Mariandyshev A.
المساهمون: Migliori G. B., Besozzi G., Girardi E., Kliiman K., Lange C., Toungoussova O. S., Ferrara G., Cirillo D. M., Gori A., Matteelli A., Spanevello A., Codecasa L. R., Raviglione M. C., Ortmann J., Kirsten D., Ruesch-Gerdes S., Piana F., Ferrarese M., De Iaco G., De Lorenzo S., Troupioti P., Fattorini L., Iona E., Gualano A., De Mori P., Centis R., Danilovits M., Hollo V., Mariandyshev A.
مصطلحات موضوعية: Clinical value, Drug resistance, Extensively drug-resistant tuberculosi, Multidrug-resistant tuberculosi, Tuberculosi, Antitubercular Agent, Communicable Disease, Multiple, Global Health, Human, Isoniazid, Population Surveillance, Public Health, Rifampin, Risk, Russia, Time Factor, Treatment Outcome
Relation: info:eu-repo/semantics/altIdentifier/pmid/17690121; info:eu-repo/semantics/altIdentifier/wos/WOS:000250135400006; volume:30; issue:4; firstpage:623; lastpage:626; numberofpages:4; journal:EUROPEAN RESPIRATORY JOURNAL; http://hdl.handle.net/11379/533284; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-36849040101
-
5Academic Journal
المؤلفون: Toungoussova, O. S., Mariandyshev, A. O., Bjune, G., Caugant, D. A., Sandven, P.
المصدر: European Journal of Clinical Microbiology & Infectious Diseases ; volume 24, issue 3, page 202-206 ; ISSN 0934-9723 1435-4373
-
6
المؤلفون: Migliori, G. B., Besozzi, G., Girardi, E., Kliiman, K., Lange, C., Toungoussova, O. S., Ferrara, G., Cirillo, D. M., Gori, A., Matteelli, A., Spanevello, A., Codecasa, L. R., Raviglione, M. C., Ortmann, J., Kirsten, D., Ruesch-Gerdes, S., Piana, F., Ferrarese, M., De Iaco, G., De Lorenzo, S., Troupioti, P., Fattorini, L., Iona, E., Gualano, A., De Mori, P., Centis, R., Danilovits, M., Hollo, V., Mariandyshev, A.
المصدر: Karolinska Institutet
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Risk, medicine.medical_specialty, Tuberculosis, Time Factors, medicine.medical_treatment, Extensively Drug-Resistant Tuberculosis, Antitubercular Agents, Drug Resistance, Drug resistance, Global Health, Communicable Diseases, Russia, Multidrug-resistant tuberculosis, Isoniazid, Medicine, tuberculosis MYCOBACTERIUM-TUBERCULOSIS, Humans, Clinical value, Extensively drug-resistant tuberculosis, Drug Resistance, Multiple, Population Surveillance, Public Health, Rifampin, Treatment Outcome, Intensive care medicine, Ethambutol, business.industry, Pyrazinamide, medicine.disease, Surgery, clinical value, drug resistance, extensively drug-resistant tuberculosis, multidrug-resistant tuberculosis, tuberculosis MYCOBACTERIUM-TUBERCULOSIS, Tuberculosis management, business, Multiple, Rifampicin, medicine.drug
-
7Academic Journal
المؤلفون: Toungoussova, O. S., Nizovtseva, N. I., Mariandyshev, A. O., Caugant, D. A., Sandven, P., Bjune, G.
المصدر: European Journal of Clinical Microbiology & Infectious Diseases ; volume 23, issue 3, page 174-179 ; ISSN 0934-9723 1435-4373
-
8Academic Journal
المؤلفون: Toungoussova, O. S., Mariandyshev, A. O., Bjune, G., Caugant, D. A., Sandven, P.
المصدر: European Journal of Clinical Microbiology & Infectious Diseases; Mar2005, Vol. 24 Issue 3, p202-206, 5p
مصطلحات موضوعية: DRUG resistance in microorganisms, PHARMACOLOGY, MYCOBACTERIAL diseases, LUNG diseases, TUBERCULOSIS, DRUG resistance